Dyadic International

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DYAI and other ETFs, options, and stocks.

About DYAI

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. 

CEO
Mark A. Emalfarb
CEOMark A. Emalfarb
Employees
6
Employees6
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
1987
Founded1987
Employees
6
Employees6

DYAI Key Statistics

Market cap
28.13M
Market cap28.13M
Price-Earnings ratio
-4.78
Price-Earnings ratio-4.78
Dividend yield
Dividend yield
Average volume
88.24K
Average volume88.24K
High today
$0.9889
High today$0.9889
Low today
$0.9178
Low today$0.9178
Open price
$0.96
Open price$0.96
Volume
112.28K
Volume112.28K
52 Week high
$2.20
52 Week high$2.20
52 Week low
$0.912
52 Week low$0.912

DYAI News

TipRanks 3d
Dyadic International rebrands as Dyadic Applied BioSolutions

Dyadic International (DYAI) announced that, effective in 30 days, it will be doing business as Dyadic Applied BioSolutions, marking a pivotal step in the compan...

People also own

Based on the portfolios of people who own DYAI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.